Triomics raised $15 million in Series A funding to accelerate automating cancer clinical trials matching, reducing the time to match patients with suitable trials, filling a critical gap in cancer care.
Triomics' platform uses generative AI technology to streamline trial matching by swiftly identifying relevant trials tailored to each patient's unique profile, potentially saving lives and advancing cancer research.
[
add
]
[
|
|
...
]